Thursday 21 September 2017

polysilicon market anticipated to reach USD 13.56 billion by 2025 : Grand View Research,Inc.

The global polysiliconmarket is anticipated to reach USD 13.56 billion by 2025, according to a new report by Grand View Research, Inc. The growing solar PV (photovoltaic) and electronic industry are expected to propel market demand over the coming years. The FBR technology used in the production of polysilicon has helped to reduce manufacturing cost to a large extent, thus lowering prices of polysilicon in 2014. Increasing solar photovoltaic installations is projected to impact market growth positively. Polysilicon is also used in the fabrication of crystalline silicon wafers, which is the backbone of the microelectronics industry.
Asia Pacific occupied the largest share of the global polysilicon market on account of a vast number of solar installations in countries such as China, India, Japan, and South Korea. The low cost of solar grade polysilicon is expected to propel market demand over the forecast period.
Browse full report by Grand View Research :
Further Key Findings from the Study Suggest:
·         Huge investments in renewable energy projects across the world is expected to boost the demand for polysilicon over the forecast period
·         Asia Pacific is projected to grow at the highest CAGR with China leading the market share
·         PV capacity expansion projects undertaken in Asia Pacific coupled with the growth of the semiconductor industry is anticipated to complement market growth within the region
·         North America occupied the second largest share in 2015 on account of high polysilicon demand in the U.S. electronics and solar energy industry
·         Implementation of anti-dumping policies is anticipated to restrain market growth over the forecast period
·         The fluidized bed reactor (FBR) technology used for the manufacture of solar grade polysilicon helps to reduce manufacturing cost to a large extent
·         Some of the companies that have adopted the FBR technology for the manufacture of polysilicon include REC Silicone, GCL Poly, and SunEdison Inc.
·         According to the International Technology Roadmap for Photovoltaics (ITRPV), FBR technology used in the manufacture of polysilicon is projected to occupy 30% of the market share by 2017
·         Chinese duties and the oversupply scenario experienced by the polysilicon market in 2013 led to plant shutdowns of company’s such as REC Silicon, SunEdison, Hemlock
·         Companies operating in this market include GCL-Poly, Wacker Chemie AG, OIC Chemical, REC Silicon, Tokuyama, LDK Solar Co. Ltd., Hemlock Semiconductor Group, and TBEA Co. Ltd.   
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/specialty-bio-based-and-water-soluble-polymers
Grand View Research has segmented the global polysilicon market on the basis of application and region:
Polysilicon Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         Photovoltaic
·         Electronics
Polysilicon Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    UK
o    Germany
o    France
o    Italy
·         Asia Pacific
o    China
o    Japan
o    India
o    South Korea
o    Australia
·         CSA
o    Chile
o    Honduras
·         MEA
o    South Africa
o    Algeria
View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-polysilicon-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit: www.grandviewresearch.com


at No comments:

Prefilled Syringes Market Anticipated to reach USD 22.5 Billion by 2025 : Grand View Research,Inc.

Global Prefilled Syringes Market size is expected to reach USD 22.5 Billion by 2025, according to a new study by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.
Prefilled injecting devices are rapidly replacing traditional syringe-vial combinations due to certain associated advantages such as increased patient safety and convenience offered to healthcare practitioners in dose preparation. Growing trend of self-injecting devices adopted for the management of chronic diseases, such as diabetes and rheumatoid arthritis, are expected to boost the growth of auto injectors and pen injectors during the forecast period. Growing prevalence of these diseases and introduction of advanced devices with Wi-Fi and Bluetooth connectivity that facilitate effective management of patient health records are factors expected to boost the usage of such devices.
Application of prefilled injectors is currently limited to emergency rooms in hospitals and for the treatment of certain chronic diseases. These injection devices are considered ideal containers for vaccines and biotech drugs, which otherwise tend to become unstable and react with the material of the container that result in altered drug potency. Growing preference toward biotechnology drugs and the emerging biotech space presenting greater opportunities are expected to have a positive impact on the growth of the prefilled syringes market during the forecast period. 
Full Research Report on Global Prefilled Syringes Market Analysis:
http://www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market
Further key findings from the study suggest:
  • The use of glass syringes to be high owing to their increasing preference amongst healthcare professionals; this is attributable to their ease of use and the low risk posed by these devices at the time of injection.
  • However, the plastic segmentis rapidly replacing the former with the introduction of advanced plastic materials, such as polypropylene and crystal clear polymer, which are biocompatible as glass.
  • Europe dominated the prefilled syringes space in 2015. High adoption of patient safety measures and presence of large number of market players are the factors responsible for the dominance of the region.
  • North America region is expected to show the fastest growth rate during the forecast period due to rapid adoption of prefilled syringes in this region.
  • The market is presently dominated by few key participants such as Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Unilife Corporation,Owen Mumford, SCHOTT, Datwyler Pharma Packaging, and Becton, Dickinson and Company.
  • The syringe manufacturing market is consolidated; however, various new players are bringing innovative technologies to this sphere,which can be used for the manufacturing of auto-injectors.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the Global Prefilled Syringes Market by type, material, application, distribution channel, and region:
Prefilled Syringes Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Disposable Prefilled Syringes
  • Reusable Prefilled Syringes
Prefilled Syringes Material Outlook (Revenue, USD Million; 2014 - 2025)
  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes
Prefilled Syringes Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Others (Vaccines and other biotech drugs)
Prefilled Syringes Distribution Channel Outlook (Revenue, USD Million; 2014 - 2025)
  • Hospitals
  • Mail Order Pharmacies
  • Ambulatory Surgery Centers
Prefilled Syringes Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa
View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-prefilled-syringes-market                       
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit: www.grandviewresearch.com



at No comments:

cell culture market expected to reach USD 37.0 billion by 2022 : Grand View Research,Inc.

The global cell culture market is expected to reach USD 37.0 billion by 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the growing need for biopharmaceutical development, vaccine research and development, and protein production; all of which rely heavily on cytological R&D in which cell culture plays a pivotal role. 
The development and commercialization of integrated robotic liquid handling laboratory automation culture systems is also expected to considerably enhance growth over the forecast period. These systems provide highly improved capacity handling, higher efficiency and reproducible purity levels. 
Further key findings from the report suggest:
·         Cell culture sera accounted for over 50% of revenue generated in 2014 owing to, high usage rates of serum in the composition of cell cultures and their relatively high average market prices. Furthermore, commercialization of serum free sera is also expected to drive market demand in the coming years. 
·         Culture reagents including amino acids, cofactors, thrombin, and growth factors, even though used in trace quantities, account for a considerably large share of revenue owing to their relatively expensive prices. 
·         North America accounted for the largest share of this market in 2014, as there are a significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for biopharmaceuticals is also anticipated to fuel regional market growth during the forecast period. 
·         Rising demand, for cell culture technology and cell biology research in Europe has shown significant development and companies have started investing in innovative technologies and advances in cell culture applications. 
·         Asia Pacific is expected to witness significant growth in demand over the forecast period owing to the presence of high unmet need for increasing production and development of vaccines, drugs, and new biologics. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in biopharmaceutical manufacturing and high untapped market opportunities are some important factors accounting for such rapid growth in demand. 
·         Key participants of the cell culture market include Sartorius, Thermo Fisher Scientific, General Electric, Merck, Sigma-Aldrich Co., LLC, Corning, Lonza, Promocell, Becton, Dickinson & Company, and Eppendorf. 
·         Market participants are involved in extensive R&D of 3D cell culture and full commercialization of the technologically advanced cell culture which offer higher accuracy of replication, greater purity and rapid growth 
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented cell culture market on the basis of consumables, products, applications and regions:
Cell Culture Consumables Outlook (Market Revenue in USD Billion, 2012 - 2022 )
·         Media
o    Minimum Essential Media (MEM)
o    RPMI 1640 Media
o    DMEM/F-12 Media
o    F-10 Serum Free Media
o    BME Media
o    Insect Media
o    Other Media
·         Sera
o    Fetal Bovine Serum
o    Other Animals’ serum
·         Reagents
o    Albumin
o    Other
Cell Culture Product Outlook (Market Revenue in USD Billion, 2012 - 2022 )
·         Culture Systems
·         Incubators
·         Centrifuges
·         Pipetting Instruments
·         Biosafety Equipment
·         Cryostorage Equipment
Cell Culture Applications Outlook (Market Revenue in USD Billion, 2012 - 2022 )
·         Biopharmaceuticals
·         Cancer Research
·         Drug Development
·         Gene Therapy
·         Tissue Culture & Engineering
·         Toxicity testing
·         Vaccine Production
Cell Culture Regional Outlook (Revenue, USD Million, 2012 - 2022)
·         North America
·         Europe
·         Asia Pacific
·         RoW

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cell-culture-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit: www.grandviewresearch.com




at No comments:

Cancer Diagnostics Market Estimated to reach USD 232.7 billion by 2025 : Grand View Research,inc.

Global Cancer Diagnostics Market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.
Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.
Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.
Full Research Report on Global Cancer Diagnostics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market
Further Key Findings from the Study Suggest:
  • Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.
  • The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.
  • In 2016, North America dominated the global space with the largest revenue share of more than 41%. Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.
  • Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic, Inc.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the Global Cancer Diagnostics Market by screening type, application, and region:
Cancer Diagnostics Screening Type Outlook (Revenue, USD Billion; 2014 - 2025)
  • Laboratory Tests
  • Genetic Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others (barium enema)
Cancer Diagnostics Application Outlook (Revenue, USD Billion; 2014 - 2025)
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others
Cancer Diagnostics Regional Outlook (Revenue, USD Billion; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa
View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cancer-diagnostics-market                          
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit: www.grandviewresearch.com




at No comments:

Top 6 Infectious DiseaseTherapeutics Market Estimated to reach USD 86.2 billion by 2025 : Grand View Research,inc.

Global Top 6 Infectious DiseaseTherapeutics Market is expected to reach USD 86.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.
Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.
In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.
North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.
Full Research Report On Global Infectious Disease Therapeutics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/infectious-disease-therapeutics-market
Further Key Findings From the Report Suggest:
  • The HIV therapeutics segment held the largest revenue share in 2016 due to high number of HIV cases globally
  • North America dominated the global market owing to the strong reimbursement framework coupled with high adoption rate of treatments for infectious diseases
  • The HPV therapeutics segment is estimated to grow at the highest rate during the forecast period
  • Some of the key players areNovartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the Top 6 Infectious Disease Therapeutics Market on the basis of disease type and region:
Disease Type Outlook (Revenue, USD Million, 2014 - 2025)
  • HIV
    • Emtriva
    • Aptivus
    • Isentress
    • Lexiva/Telzir
    • Selzentry
    • Tivicay 
    • Atripla
    • Complera
    • Genvoya
    • Odefsey
    • Stribild
    • Truvada
    • Triumeq
    • Descovy
    • Vitekta
    • Others
  • Influenza
    • Relenza
    • Tamiflu 
    • Rapivab 
    • Others
  • TB
    • Sirturo
    • Others
  • Malaria
    • Coartem
    • Others
  • HPV
  • Hepatitis
Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-infectious-disease-therapeutics-market                         
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com
at No comments:

Prefilled Syringes Market Expected to reach USD 22.5 Billion by 2025 : Grand View Research,Inc.

Global Prefilled Syringes Market size is expected to reach USD 22.5 Billion by 2025, according to a new study by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.
Prefilled injecting devices are rapidly replacing traditional syringe-vial combinations due to certain associated advantages such as increased patient safety and convenience offered to healthcare practitioners in dose preparation. Growing trend of self-injecting devices adopted for the management of chronic diseases, such as diabetes and rheumatoid arthritis, are expected to boost the growth of auto injectors and pen injectors during the forecast period. Growing prevalence of these diseases and introduction of advanced devices with Wi-Fi and Bluetooth connectivity that facilitate effective management of patient health records are factors expected to boost the usage of such devices.
Application of prefilled injectors is currently limited to emergency rooms in hospitals and for the treatment of certain chronic diseases. These injection devices are considered ideal containers for vaccines and biotech drugs, which otherwise tend to become unstable and react with the material of the container that result in altered drug potency. Growing preference toward biotechnology drugs and the emerging biotech space presenting greater opportunities are expected to have a positive impact on the growth of the prefilled syringes market during the forecast period. 
Full Research Report on Global Prefilled Syringes Market Analysis:
http://www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market
Further key findings from the study suggest:
  • The use of glass syringes to be high owing to their increasing preference amongst healthcare professionals; this is attributable to their ease of use and the low risk posed by these devices at the time of injection.
  • However, the plastic segmentis rapidly replacing the former with the introduction of advanced plastic materials, such as polypropylene and crystal clear polymer, which are biocompatible as glass.
  • Europe dominated the prefilled syringes space in 2015. High adoption of patient safety measures and presence of large number of market players are the factors responsible for the dominance of the region.
  • North America region is expected to show the fastest growth rate during the forecast period due to rapid adoption of prefilled syringes in this region.
  • The market is presently dominated by few key participants such as Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Unilife Corporation,Owen Mumford, SCHOTT, Datwyler Pharma Packaging, and Becton, Dickinson and Company.
  • The syringe manufacturing market is consolidated; however, various new players are bringing innovative technologies to this sphere,which can be used for the manufacturing of auto-injectors.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the Global Prefilled Syringes Market by type, material, application, distribution channel, and region:
Prefilled Syringes Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Disposable Prefilled Syringes
  • Reusable Prefilled Syringes
Prefilled Syringes Material Outlook (Revenue, USD Million; 2014 - 2025)
  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes
Prefilled Syringes Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Others (Vaccines and other biotech drugs)
Prefilled Syringes Distribution Channel Outlook (Revenue, USD Million; 2014 - 2025)
  • Hospitals
  • Mail Order Pharmacies
  • Ambulatory Surgery Centers
Prefilled Syringes Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa
View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-prefilled-syringes-market                       
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit: www.grandviewresearch.com



at No comments:
Subscribe to: Posts (Atom)